SmartTab's oral capsule for colon targeted drug delivery. Designed specifically for targeted delivery of medication. Successfully Completed PK Pre-clinical Animal Studies.
SmartTab's oral injection capsule for biologics and large molecules. Making injections with needles a thing of the past. Currently in the process of PK Pre-clinical Animal Studies.
SmartTab's multi-compartment capsule to reside in the stomach for a week with active ingredients to release each day. To begin PK Pre-clinical Animal Studies in 2022.
InjectTab™ is an oral delivery system for biologics and large molecules. A revolutionary wireless ingestible capsule designed to replace the conventional needle and syringe.
TargetTab™ is an ingestible capsule for wireless, targeted drug delivery. This is first application of the SmartTab Platform for Crohn's and other GI related diseases.
SmartTab recently published “Advancing High Tech Drug Delivery Systems for the Treatment of Crohn’s Disease” in Inflammatory Bowel Diseases (IBD) Journal, and the Journal of Gastroenterology. A poster of distinction, as one of the top-scoring abstracts at the Crohn's and Colitis Congress 2021.
25+ years of experience in the medical device; multi-national corporate R&D; 20+ years experience in active implantable devices; 5+ years in in-vitro diagnostics and pharmaceuticals; Led R&D, manufacturing, quality, and regulatory functions at VP level; 9 patents in the biomedical field; Published author; BS in Electrical Engineering; MS & PhD in Electrical/Biomedical Engineering.
December 12, 2020